Results 201 to 210 of about 119,001 (387)

High Prevalence of Inappropriate Benzodiazepine and Sedative Hypnotic Prescriptions among Hospitalized Older Adults

open access: yesJournal of Hospital Medicine, 2017
E. Pek   +5 more
semanticscholar   +1 more source

Parasomnias and sleep‐related movement disorders induced by drugs in the adult population: a review about iatrogenic medication effects

open access: yesJournal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary Parasomnias and sleep‐related movement disorders (SRMD) are major causes of sleep disorders and may be drug induced. The objective of this study was to conduct a systematic review of the literature to examine the association between drug use and the occurrence of parasomnias and SRMD.
Sylvain Dumont   +5 more
wiley   +1 more source

Respiratory safety of lemborexant in adult and elderly subjects with moderate‐to‐severe chronic obstructive pulmonary disease

open access: yesJournal of Sleep Research, Volume 34, Issue 2, April 2025.
Lemborexant 10 mg, a dual orexin‐receptor antagonist (DORA), did not elicit respiratory depressant effects, as measured by peripheral oxygen saturation (SpO2) or apnea–hypopnea index (AHI), in subjects with moderate‐to‐severe chronic obstructive pulmonary disease (COPD).
Jocelyn Y. Cheng   +3 more
wiley   +1 more source

Rectal Use of Pentothal?? As Basal Hypnotic in Pediatric Surgery.

open access: bronze, 1953
W. Migdal   +2 more
openalex   +1 more source

Dreaming in patients with epilepsy: a cross‐sectional cohort study

open access: yesJournal of Sleep Research, EarlyView.
Dream recall frequency in patients with epilepsy is modulated by determinants shared with healthy subjects (age, nocturnal awakenings, role of the parieto‐occipital region) and by epilepsy‐related factors (seizure frequency, epileptic focus location).
Maïlis Charpentier‐Hélary   +11 more
wiley   +1 more source

A randomised crossover trial of daridorexant for the treatment of chronic insomnia and nocturia

open access: yesJournal of Sleep Research, EarlyView.
Summary This double‐blind, placebo‐controlled, two‐way crossover trial evaluated the efficacy and safety of daridorexant in patients with chronic insomnia and comorbid nocturia. In total, 60 patients aged ≥55 years with insomnia complaints for ≥3 months, Insomnia Severity Index (ISI) ≥13 and ≥3 voids/night for ≥1 month were randomised (1:1) to ...
Katharina Lederer   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy